کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5518387 | 1543954 | 2017 | 6 صفحه PDF | دانلود رایگان |
- First report about ADA (22GÂ >Â A) polymorphism in SCA from Rio de Janeiro State
- ADA frequency was lower than that reported for Caucasians.
- ADA frequency was higher than that expected for African descents.
- ADA does not play role in the disruption of sickle erythrocyte redox metabolism.
The aim of this study was to identify, in people with sickle cell anemia (SCA), adenosine deaminase (ADA; c. 22G > A; rs73598374) polymorphism, and correlating it with oxidative stress markers. We evaluated 95 unrelated and diagnosed Brazilian sickle cell anemia (SCA) patients. All patients received a prophylactic treatment with folic acid of 5 mg/day, while 41 (43.2%) of them were under hydroxycarbamide (HC) treatment (average dose: 22 mg/kg/day). ADA polymorphism was identified by PCR-RFLP. Biochemical parameters were measured using spectrophotometric [catalase, glutathione S-transferase, glutathione peroxidase, glutathione reductase activities] and chromatographic methods [fetal hemoglobin (HbF), glutathione (GSH) and malondialdehyde (MDA) levels]. Among the 95 SCA patients, we identified 80 (84.2%) wild homozygous for ADA (22GG), 15 (15.8%) heterozygous (22GA) and none mutant homozygous (22AA), leading to an allelic frequency of 0.92 for the ancestral allele (22G) and 0.08 for the mutant one (22A). Unexpectedly, we did not observe any influence of ADA polymorphism on oxidative stress markers, as well as interaction effects with HC usage. However, we confirmed a well-described protective effect of HC treatment on decreasing MDA levels (p = 0.03). Thus, we concluded that ADA (22G > A) polymorphism does not play significant role in the disruption of sickle erythrocyte redox metabolism.
Journal: Meta Gene - Volume 11, February 2017, Pages 172-177